What's breaking now, across thousands of outlets.
Meta “streamlined” its commercial TOS. Legal experts warn it’s an AI power grab.
We haven't written up this one. Ars Technica has the full story — the link below goes straight to it.
(MedPage Today) -- Zydus Lifesciences and Formycon AG announced FDA acceptance of a biologics license application for FYB206, a biosimilar to the blockbuster cancer drug pembrolizumab (Keytruda).
How Raven, previously known as Geospy, can now find which house a photo was taken in; why a judge ruled a Flock search unconstitutional; and the wild AI video in a court case.
To build faster and more energy-efficient computers, researchers need to understand nanoscale magnetic materials. But looking inside these tiny magnets is surprisingly difficult: Modern microscopes…
With Ireland's lucrative tech sector hit by waves of layoffs linked to AI, the country's nascent tech union has seen a spike in sign-ups from workers worried about their future.
From the Hugging Face attack to government breaches, researchers say the rogue AI incidents result from how companies train their models, and the race to ship them.
Think of Muse Spark Open as the result of Meta and Apple’s enemies-to-lovers arc.
